The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

The Food and Drug Administration has upgraded its classification of a broccoli recall initially reported in late December, ...

On Dec. 12, 2024, Cal Yee Farm, a California-based company, announced a recall on a variety of products, including dark ...

The FDA has upgraded a recall issued on 12-ounce Marketside Broccoli Florets that were initially sold at select Walmart ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to ...

The (FDA) has announced several Class 1 recalls, the highest risk level, for various food products sold across multiple ...

The medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...